According to the World Health Organization (WHO), osteoporosis ranks second only to cardiovascular disease as the world’s leading health care problem and one in three women in the Middle East is at risk of developing the disease.
Anlene’s 14-hour event in The Star Atrium at The Dubai Mall was a step in the right direction in the battle for women of all ages to take osteoporosis seriously, says Kamal Gupta, Managing Director, Fonterra Brands Middle East and Africa. “It was very encouraging to see so many women taking the five-minute bone scan, trying the move stations and getting advice from experts about how they can realistically improve their bone health on a daily basis. We have shown it is possible for women to adapt their lifestyle to incorporate healthy activities without having to make drastic changes.”
Since 2005 Fonterra, Anlene’s parent company, has conducted more than five million bone scans in Asia and the Middle East as part of its research programme to raise awareness of the growing incidence of osteoporosis in the region. The data secured provides valuable insight into the state of bone health in the region.
To date, Anlene’s parent company Fonterra has spent over US$50 million on bone health research to increase its understanding of osteoporosis and the role of dairy in its prevention. This includes 18 clinical trials to evaluate how dairy best supports bone health. Fonterra is the International Osteoporosis Foundation’s (IOF’s) Regional Nutrition Partner in the Middle East. The partnership is dedicated to raising awareness of osteoporosis and improving bone health.
As part of this, Anlene, a nutrient-rich adult milk and range of dairy products was developed by Fonterra almost 20 years ago to promote good bone health. The range was introduced to the UAE in June 2007. It includes a formulation of calcium, vitamin D, vitamin K, zinc and magnesium which combine to assist the effective absorption of bone nutrients and improve bone quality.
Saturday, April 28- 2012 @ 13:30 UAE local time (GMT+4) Replication or redistribution in whole or in part is expressly prohibited without the prior written consent of Mediaquest FZ LLC.